A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor positive breast cancer
View ORCID ProfileJoanna I. López-Velazco, View ORCID ProfileSara Manzano, María Otaño, Kepa Elorriaga, Núria Bultó, Julio Herrero, Ainhara Lahuerta, Virginia Segur, View ORCID ProfileIsabel Álvarez-López, View ORCID ProfileMaria M. Caffarel, View ORCID ProfileAnder Urruticoechea
doi: https://doi.org/10.1101/2023.02.02.23285373
Joanna I. López-Velazco
1Biodonostia Health Research Institute, San Sebastian, Spain
Sara Manzano
1Biodonostia Health Research Institute, San Sebastian, Spain
María Otaño
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Kepa Elorriaga
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Núria Bultó
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Julio Herrero
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Ainhara Lahuerta
1Biodonostia Health Research Institute, San Sebastian, Spain
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Virginia Segur
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Isabel Álvarez-López
1Biodonostia Health Research Institute, San Sebastian, Spain
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Maria M. Caffarel
1Biodonostia Health Research Institute, San Sebastian, Spain
3IKERBASQUE, Basque Foundation for Science, Bilbao, Spain
Ander Urruticoechea
1Biodonostia Health Research Institute, San Sebastian, Spain
2Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain
Article usage
Posted August 11, 2023.
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor positive breast cancer
Joanna I. López-Velazco, Sara Manzano, María Otaño, Kepa Elorriaga, Núria Bultó, Julio Herrero, Ainhara Lahuerta, Virginia Segur, Isabel Álvarez-López, Maria M. Caffarel, Ander Urruticoechea
medRxiv 2023.02.02.23285373; doi: https://doi.org/10.1101/2023.02.02.23285373
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor positive breast cancer
Joanna I. López-Velazco, Sara Manzano, María Otaño, Kepa Elorriaga, Núria Bultó, Julio Herrero, Ainhara Lahuerta, Virginia Segur, Isabel Álvarez-López, Maria M. Caffarel, Ander Urruticoechea
medRxiv 2023.02.02.23285373; doi: https://doi.org/10.1101/2023.02.02.23285373
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)